Document and Entity Information
v6.14.0.7
Document and Entity Information
3 Months Ended
Mar. 31, 2017
May 10, 2017
Document and Entity Information [Abstract]    
Entity Registrant Name MICRON SOLUTIONS INC /DE/  
Entity Central Index Key 0000819689  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Document Type 10-Q  
Document Period End Date Mar. 31, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Entity Common Stock, Shares Outstanding   2,820,999dei_EntityCommonStockSharesOutstanding

Condensed Consolidated Balance Sheets
v6.14.0.7
Condensed Consolidated Balance Sheets (USD $)
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 265,142us-gaap_CashAndCashEquivalentsAtCarryingValue $ 380,381us-gaap_CashAndCashEquivalentsAtCarryingValue
Trade accounts receivable, net of allowance for doubtful accounts of $36,000 at March 31, 2017 and $30,000 at December 31, 2016 3,241,771us-gaap_AccountsReceivableNetCurrent 2,276,608us-gaap_AccountsReceivableNetCurrent
Inventories 3,353,283us-gaap_InventoryNet 3,060,085us-gaap_InventoryNet
Prepaid expenses and other current assets 577,146us-gaap_PrepaidExpenseAndOtherAssetsCurrent 614,362us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 7,437,342us-gaap_AssetsCurrent 6,331,436us-gaap_AssetsCurrent
Property, plant and equipment, net 6,528,482us-gaap_PropertyPlantAndEquipmentNet 6,440,911us-gaap_PropertyPlantAndEquipmentNet
Assets held for sale, net 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup
Intangible assets, net 34,935us-gaap_IntangibleAssetsNetExcludingGoodwill 30,093us-gaap_IntangibleAssetsNetExcludingGoodwill
Other assets 135,345us-gaap_OtherAssetsNoncurrent 156,231us-gaap_OtherAssetsNoncurrent
Total assets 14,824,854us-gaap_Assets 13,647,421us-gaap_Assets
Current liabilities:    
Revolving line of credit 2,610,795micr_RevolvingLineOfCreditCurrentPortion 1,785,795micr_RevolvingLineOfCreditCurrentPortion
Equipment line of credit 416,949micr_EquipmentLineOfCreditCurrentPortionDue 102,500micr_EquipmentLineOfCreditCurrentPortionDue
Term notes payable, current portion 478,144micr_TermNotesPayableCurrentPortion 487,468micr_TermNotesPayableCurrentPortion
Accounts payable 2,076,887us-gaap_AccountsPayableCurrent 1,744,261us-gaap_AccountsPayableCurrent
Accrued expenses and other current liabilities 434,847us-gaap_OtherLiabilitiesCurrent 333,361us-gaap_OtherLiabilitiesCurrent
Customer deposits 93,642us-gaap_CustomerDepositsCurrent 122,290us-gaap_CustomerDepositsCurrent
Deferred revenue, current 186,764us-gaap_DeferredRevenueCurrent 224,988us-gaap_DeferredRevenueCurrent
Total current liabilities 6,298,028us-gaap_LiabilitiesCurrent 4,800,663us-gaap_LiabilitiesCurrent
Long-term liabilities:    
Term notes payable, non-current portion 1,860,208micr_TermNotesPayableNonCurrentPortion 1,970,863micr_TermNotesPayableNonCurrentPortion
Subordinated promissory notes 434,229us-gaap_SubordinatedLongTermDebt 432,011us-gaap_SubordinatedLongTermDebt
Deferred revenue, non-current portion 132,953us-gaap_DeferredRevenueNoncurrent 156,953us-gaap_DeferredRevenueNoncurrent
Total long-term liabilities 2,427,390us-gaap_LiabilitiesNoncurrent 2,559,827us-gaap_LiabilitiesNoncurrent
Total liabilities 8,725,418us-gaap_Liabilities 7,360,490us-gaap_Liabilities
Commitments and Contingencies      
Shareholders' equity:    
Preferred stock, $0.001 par value; 2,000,000 shares authorized, none issued      
Common stock, $0.01 par value; 10,000,000 shares authorized; 3,926,491 issued, 2,820,999 outstanding at March 31, 2017 and 3,926,491 issued, 2,816,639 outstanding at December 31, 2016 39,265us-gaap_CommonStockValue 39,265us-gaap_CommonStockValue
Additional paid-in-capital 11,471,643us-gaap_AdditionalPaidInCapital 11,457,320us-gaap_AdditionalPaidInCapital
Treasury stock at cost, 1,105,492 shares at March 31, 2017 and 1,109,852 shares at December 31, 2016 (3,016,667)us-gaap_TreasuryStockValue (3,028,564)us-gaap_TreasuryStockValue
Accumulated deficit (2,394,805)us-gaap_RetainedEarningsAccumulatedDeficit (2,181,090)us-gaap_RetainedEarningsAccumulatedDeficit
Total shareholders’ equity 6,099,436us-gaap_StockholdersEquity 6,286,931us-gaap_StockholdersEquity
Total liabilities and shareholders’ equity $ 14,824,854us-gaap_LiabilitiesAndStockholdersEquity $ 13,647,421us-gaap_LiabilitiesAndStockholdersEquity

Condensed Consolidated Balance Sheets (Parenthetical)
v6.14.0.7
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
Mar. 31, 2017
Dec. 31, 2016
Condensed Consolidated Balance Sheets [Abstract]    
Allowance for doubtful accounts receivable, current $ 36,000us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent $ 30,000us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent
Preferred stock, par value per share $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare $ 0.001us-gaap_PreferredStockParOrStatedValuePerShare
Preferred stock, shares authorized 2,000,000us-gaap_PreferredStockSharesAuthorized 2,000,000us-gaap_PreferredStockSharesAuthorized
Preferred stock, shares issued 0us-gaap_PreferredStockSharesIssued 0us-gaap_PreferredStockSharesIssued
Common stock, par value per share $ 0.01us-gaap_CommonStockParOrStatedValuePerShare $ 0.01us-gaap_CommonStockParOrStatedValuePerShare
Common stock, shares authorized 10,000,000us-gaap_CommonStockSharesAuthorized 10,000,000us-gaap_CommonStockSharesAuthorized
Common stock, shares issued 3,926,491us-gaap_CommonStockSharesIssued 3,926,491us-gaap_CommonStockSharesIssued
Common stock, shares outstanding 2,820,999us-gaap_CommonStockSharesOutstanding 2,816,639us-gaap_CommonStockSharesOutstanding
Treasury stock, shares 1,105,492us-gaap_TreasuryStockShares 1,109,852us-gaap_TreasuryStockShares

Condensed Consolidated Statements of Operations
v6.14.0.7
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Condensed Consolidated Statements of Operations [Abstract]    
Net sales $ 5,264,977us-gaap_SalesRevenueNet $ 4,983,281us-gaap_SalesRevenueNet
Cost of sales 4,526,882us-gaap_CostOfGoodsAndServicesSold 4,298,162us-gaap_CostOfGoodsAndServicesSold
Gross profit 738,095us-gaap_GrossProfit 685,119us-gaap_GrossProfit
Selling and marketing 265,873us-gaap_SellingAndMarketingExpense 293,346us-gaap_SellingAndMarketingExpense
General and administrative 616,829us-gaap_GeneralAndAdministrativeExpense 690,635us-gaap_GeneralAndAdministrativeExpense
Research and development 29,296us-gaap_ResearchAndDevelopmentExpense 25,843us-gaap_ResearchAndDevelopmentExpense
Total operating expenses 911,998us-gaap_OperatingExpenses 1,009,824us-gaap_OperatingExpenses
Net loss from operations (173,903)us-gaap_OperatingIncomeLoss (324,705)us-gaap_OperatingIncomeLoss
Other expense:    
Interest expense (63,901)us-gaap_InterestExpense (60,220)us-gaap_InterestExpense
Other income, net 24,089us-gaap_OtherNonoperatingIncomeExpense 777us-gaap_OtherNonoperatingIncomeExpense
Total other expense, net (39,812)micr_OtherExpenseNet (59,443)micr_OtherExpenseNet
Loss before income tax provision (benefit) (213,715)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (384,148)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax provision (benefit)      
Net loss $ (213,715)us-gaap_NetIncomeLoss $ (384,148)us-gaap_NetIncomeLoss
Earnings (loss) per share - basic and diluted $ (0.08)us-gaap_EarningsPerShareBasicAndDiluted $ (0.14)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding - basic and diluted 2,818,819us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 2,816,144us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Condensed Consolidated Statements of Cash Flows
v6.14.0.7
Condensed Consolidated Statements of Cash Flows (USD $)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Net loss $ (213,715)us-gaap_NetIncomeLoss $ (384,148)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Gain on sale of property, plant and equipment (12,315)us-gaap_GainLossOnSaleOfPropertyPlantEquipment  
Depreciation and amortization 395,559us-gaap_DepreciationDepletionAndAmortization 361,440us-gaap_DepreciationDepletionAndAmortization
Non-cash interest expense 8,364micr_NonCashInterestExpense 6,921micr_NonCashInterestExpense
Changes in allowance for doubtful accounts (6,000)micr_IncreaseDecreaseInAllowanceForDoubtfulAccounts  
Share-based compensation expense 26,221us-gaap_ShareBasedCompensation 15,133us-gaap_ShareBasedCompensation
Changes in operating assets and liabilities:    
Accounts receivable (959,163)us-gaap_IncreaseDecreaseInAccountsReceivable (541,196)us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (293,198)us-gaap_IncreaseDecreaseInInventories 3,641us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other current assets 37,216us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (23,400)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Other non-current assets 20,886us-gaap_IncreaseDecreaseInOtherNoncurrentAssets 29,355us-gaap_IncreaseDecreaseInOtherNoncurrentAssets
Accounts payable 332,626us-gaap_IncreaseDecreaseInAccountsPayable 118,143us-gaap_IncreaseDecreaseInAccountsPayable
Accrued expenses and other current liabilities 101,485us-gaap_IncreaseDecreaseInAccruedLiabilities 98,993us-gaap_IncreaseDecreaseInAccruedLiabilities
Customer deposits (28,648)us-gaap_IncreaseDecreaseInCustomerDeposits 266,255us-gaap_IncreaseDecreaseInCustomerDeposits
Deferred revenue, current (38,224)us-gaap_IncreaseDecreaseInDeferredRevenue (14,294)us-gaap_IncreaseDecreaseInDeferredRevenue
Other non-current liabilities (24,000)us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities 8,097us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities
Net cash provided by (used in) operating activities of continuing operations (652,906)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (55,060)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:    
Purchases of property, plant and equipment (493,576)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (373,259)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Proceeds from sale of property, plant and equipment 23,200us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment  
Cash paid for patents and trademarks (5,281)micr_CashPaidForPatentsAndTrademarks  
Net cash provided by (used in) investing activities from continuing operations (475,657)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (373,259)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:    
Proceeds from (payments on) revolving line of credit, net 825,000micr_ProceedsFromPaymentsOnRevolvingLineOfCreditNet 470,000micr_ProceedsFromPaymentsOnRevolvingLineOfCreditNet
Proceeds from equipment line of credit 314,449micr_ProceedsFromEquipmentLineOfCredit  
Payments on term notes payable (126,125)us-gaap_RepaymentsOfMediumTermNotes (144,823)us-gaap_RepaymentsOfMediumTermNotes
Proceeds from stock option exercises   51,150us-gaap_ProceedsFromStockOptionsExercised
Net cash provided by (used in) financing activities from continuing operations 1,013,324us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 376,327us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net increase (decrease) in cash and cash equivalents (115,239)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (51,992)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of period 380,381us-gaap_Cash 272,291us-gaap_Cash
Cash and cash equivalents, end of period 265,142us-gaap_Cash 220,299us-gaap_Cash
Supplemental Cash Flow Information    
Cash paid for interest 59,086us-gaap_InterestPaid 55,579us-gaap_InterestPaid
Non-cash activities:    
Issuance of Treasury Stock for Directors Fees $ 11,250us-gaap_StockIssued1  

Basis of Presentation
v6.14.0.7
Basis of Presentation
3 Months Ended
Mar. 31, 2017
Basis of Presentation [Abstract]  
Basis of Presentation

1.  Basis of Presentation



The consolidated financial statements (the "financial statements") include the accounts of Micron Solutions, Inc.® (“Micron Solutions”) and its subsidiary, Micron Products, Inc.® ("Micron" and together with Micron Solutions, the “Company”).    All intercompany balances and transactions have been eliminated in consolidation.



The unaudited interim condensed consolidated financial statements and related notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC").  Accordingly, certain information and footnote disclosures normally included in complete financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been omitted pursuant to such rules and regulations.  These financial statements and related notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 22, 2017.  



The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. The Company's balance sheet at December 31, 2016 has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP for complete financial statements.



The information presented reflects, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial results for the interim periods presented. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. 



Operating matters and liquidity



At March 31, 2017, the outstanding balance on the Company’s revolver under its credit facility was $2,610,795. The revolver has a maturity date of June 2017 (see Note 6).  On May 9, 2017, the bank approved the renewal of the revolver for a one year term, expiring June 30, 2018 under substantially the same terms as the current revolver (see Note 10).  While the Company has experienced net losses in seven of its last nine quarters, the Company believes that the renewal of the revolver, cash flows from its operations, together with its existing working capital, increased booked orders and other resources will be sufficient to fund operations at current levels and repay debt obligations over the next twelve months; however, there can be no assurance that the Company will be able to do so.



Assessment of going concern



The Company follows accounting standard ASU No. 2014-15, ―Presentation of Financial Statements - Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The new accounting standard requires management to evaluate whether there are conditions that give rise to substantial doubt as to the Company’s ability to continue as a going concern within one year from the date of issuance of these financial statements. Substantial doubt exists when conditions and events, considered in the aggregate, indicate that it is probable that a company will be unable to meet its obligations as they become due within one year after the financial statement issuance date. Management evaluations include identifying relevant conditions and events that were known and reasonably knowable as of the date these financial statements have been issued.



At December 31, 2016, the Company identified certain conditions and events which in the aggregate required management to perform an assessment of the Company’s ability to continue as a going concern. These conditions included the Company’s ability to renew the revolver which matures in June 2017 negative financial history and the Company’s limited liquidity to meet the working capital needs to support the Company’s operations.  Similar conditions exist as of March 31, 2017. 



Management’s assessment included an analysis of the Company’s financial forecasts. Management’s assessment also considered the Company’s history of meeting financial covenants and being able to renew and refinance its debt obligations. Based on the renewal of the Company’s revolver (see Note 10), cash forecasts, expected fulfillment of booked orders from existing customers, new customer prospects, and the closing on the sale of certain real estate held for sale, the Company expects to continue to meet its financial covenants and its obligations for the next year.

 


Earnings Per Share (_EPS_)
v6.14.0.7
Earnings Per Share ("EPS")
3 Months Ended
Mar. 31, 2017
Earnings Per Share ("EPS") [Abstract]  
Earnings Per Share ("EPS")

2.  Earnings per Share ("EPS")



Basic earnings (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding.  The computation of diluted earnings (loss) per share is similar to the computation of basic earnings (loss) per share except that the denominator is increased to include the average number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued.  In addition, the numerator is adjusted for any changes in net income (loss) that would result from the assumed conversions of those potential shares.    For the three months ended March 31, 2017 and 2016 all shares are anti-dilutive.  For this reason the EPS table has been removed.

 


Inventories
v6.14.0.7
Inventories
3 Months Ended
Mar. 31, 2017
Inventories [Abstract]  
Inventories

3.  Inventories



Inventories consist of the following:







 

 

 

 

 

 



 

 

 

 

 

 



 

March 31,

 

December 31,



 

2017

 

2016

Raw materials

 

$

1,055,210 

 

$

1,027,474 

Work-in-process

 

 

726,121 

 

 

537,858 

Finished goods

 

 

1,571,952 

 

 

1,494,753 

Total

 

$

3,353,283 

 

$

3,060,085 



Silver included in raw materials, work-in-process and finished goods inventory had an estimated cost of $600,092 and $521,746 as of March 31, 2017 and December 31, 2016, respectively. 

 


Property, Plant and Equipment, net
v6.14.0.7
Property, Plant and Equipment, net
3 Months Ended
Mar. 31, 2017
Property, Plant and Equipment, net [Abstract]  
Property, Plant and Equipment, net

4.  Property, Plant and Equipment, net



Property, plant and equipment, net consist of the following:







 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

Asset Lives

 

March 31,

 

December 31,



 

(in years)

 

2017

 

2016

Machinery and equipment

 

3

to

15

 

$

17,085,287 

 

$

16,647,302 

Building and improvements

 

5

to

25

 

 

3,986,715 

 

 

3,986,715 

Vehicles

 

3

to

5

 

 

90,713 

 

 

90,713 

Furniture, fixtures, computers and software

 

3

to

5

 

 

1,508,342 

 

 

1,504,776 

Construction in progress

 

 

 

 

 

 

115,145 

 

 

402,099 

Total property, plant and equipment

 

 

 

 

 

 

22,786,202 

 

 

22,631,605 

Less: accumulated depreciation

 

 

 

 

 

 

(16,257,720)

 

 

(16,190,694)

Property, plant and equipment, net

 

 

 

 

 

$

6,528,482 

 

$

6,440,911 



For the three months ended March 31, 2017 and 2016, the Company recorded depreciation expense of $395,120 and $361,001, respectively.  

 

In January 2016, the Company entered into a Purchase and Sale Agreement (Agreement) with a Buyer (collectively the “Parties”) to sell two unoccupied buildings, with approximately 52,000 square feet, and land, at its Fitchburg, Massachusetts campus. 



In December 2016, the Parties entered into a First Amendment to the Purchase and Sale Agreement (the First Amendment) which extended the time to close to January 13, 2018.   As part of the consideration for extending the Agreement the Buyer agreed to pay certain extension fees.

 

In January 2017, the Parties entered into a Second Amendment to the Purchase and Sale Agreement (the Second Amendment) to further extend the time to close to July 2018.   The Second Amendment permits the Buyer to assign the Agreement to a third party and extends the extension fees through July 2018 or the culmination of the agreement.



At March 31, 2017 and December 31, 2016, the real estate under agreement was classified as Assets Held for Sale valued at $688,750.  The carrying value approximated the fair value less the cost to sell.

 


Intangible Assets, net
v6.14.0.7
Intangible Assets, net
3 Months Ended
Mar. 31, 2017
Intangible Assets, net [Abstract]  
Intangibles Assets, net

5.  Intangible Assets, net



The Company assesses the impairment of long-lived assets and intangible assets with finite lives annually or whenever events or changes in circumstances indicate that the carrying value may not be fully recoverable. For the three months ended March 31, 2017 and 2016, the Company did not impair any intangible assets.    



Intangible assets consist of the following:







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Estimated

 

March 31, 2017

 

December 31, 2016



 

Useful Life

 

 

 

 

Accumulated

 

 

 

 

 

 

 

Accumulated

 

 

 



 

(in years)

 

Gross

 

Amortization

 

Net

 

Gross

 

Amortization

 

Net

Patents and trademarks

 

10 

 

$

26,290 

 

$

10,177 

 

$

16,113 

 

$

26,290 

 

$

9,738 

 

$

16,552 

Patents and trademarks pending

 

 —

 

 

18,822 

 

 

 —

 

 

18,822 

 

 

13,541 

 

 

 —

 

 

13,541 

Total intangible assets

 

 

 

$

45,112 

 

$

10,177 

 

$

34,935 

 

$

39,831 

 

$

9,738 

 

$

30,093 



For the three months ended March 31, 2017 and 2016, the Company recorded amortization expense of $439 


Debt
v6.14.0.7
Debt
3 Months Ended
Mar. 31, 2017
Debt [Abstract]  
Debt

6.  Debt



The following table sets forth the items which comprise debt for the Company:





 

 

 

 

 

 



 

 

 

 

 

 



 

March 31,

 

December 31,



 

2017

 

2016

Revolving line of credit

 

$

2,610,795 

 

$

1,785,795 

Equipment line of credit

 

$

416,949 

 

$

102,500 

Subordinated promissory notes

 

$

434,229 

 

$

432,011 



 

 

 

 

 

 

Term notes payable:

 

 

 

 

 

 

Commercial term loan

 

$

2,293,498 

 

$

2,398,870 

Equipment notes

 

 

44,854 

 

 

59,461 

Total term notes payable

 

$

2,338,352 

 

$

2,458,331 



 

 

 

 

 

 

Total Debt

 

$

5,800,325 

 

$

4,778,637 







Bank Debt



The Company has a multi-year credit facility with a Massachusetts based bank.  This credit facility consists of a revolving line of credit (the "revolver"), a commercial term loan and an equipment line of credit.  The debt is secured by substantially all assets of the Company with the exception of real property.



Revolver



The revolver provides for borrowings up to 80% of eligible accounts receivable and 50% of eligible raw materials inventory.  The interest rate on the revolver is calculated at the bank's prime rate plus 0.25%  (3.75% at March 31, 2017). The revolver has a maturity date of June 2017.  Amounts available to borrow under the revolver are $848,719 at March 31, 2017. 



On May 9, 2017, the Company’s bank approved the renewal of the Company’s revolver for a one year term, expiring June 30, 2018, under substantially the same terms as the current revolver, subject to certain closing requirements.  The Company expects to close on the renewal prior to the end of June 2017.



Commercial term loan



In November 2016, the Company refinanced its bank term debt, including the commercial term loan and three equipment term loans, along with $500,000 from the revolver, into a new $2,481,943 consolidated five year commercial term loan with a maturity date in November 2021. The interest rate on the loan is a fixed 4.65% per annum and the loan requires monthly payments of principal and interest of approximately $46,500.



Equipment line of credit



In November 2016, the Company entered into an equipment line of credit that allows for advances of up to $1.0 million under the Company's multi-year credit facility. The term of this equipment line of credit is six years, maturing in November 2022, inclusive of a maximum one-year draw period. Repayment shall consist of monthly interest only payments, equal to the bank's prime rate plus 0.25% as to each advance commencing on the date of the loan through the earlier of: (i) one year from the date of the loan or (ii) the date upon which the equipment line of credit is fully advanced (the “Conversion Date”). On the Conversion Date, principal and interest payments will be due and payable monthly in an amount sufficient to pay the loan in full based upon an amortization schedule commensurate with the remaining term of the loan.



At March 31, 2017, $416,949 has been drawn on the equipment line of credit.  At December 31, 2016, $102,500 had been drawn on the equipment line of credit.



Debt issuance costs



The amount of the commercial term loan presented in the table above is net of debt issuance costs of $39,712 and $45,858 at March 31, 2017 and December 31, 2016 respectively.



Bank covenants



The bank facility contains both financial and non-financial covenants. The financial covenants include maintaining certain debt coverage and leverage ratios. The non-financial covenants relate to various matters including notice prior to executing further borrowings and security interests, mergers or consolidations, acquisitions, guarantees, sales of assets other than in the normal course of business, leasing, changes in ownership and payment of dividends. The Company was in compliance with all bank covenants as of March 31, 2017.



Other Debt



Equipment notes



In January 2013, the Company entered into two equipment notes totaling $272,500 with a financing company to acquire production equipment. The notes bear interest at the fixed rate of 4.66% and require monthly payments of principal and interest of approximately $5,000 over a five year term maturing in January 2018.



Subordinated promissory notes



In December 2013, the Company completed a private offering in which the Company sold an aggregate of $500,000 in subordinated promissory notes. The unsecured notes required quarterly interest-only payments at a rate of 10% per annum for the first two years.  In December 2015, the interest rate increased to 12% per annum.  The Company’s two largest beneficial owners of stock and a director participated in the private offering as follows:  REF Securities, LLP, beneficial owner of approximately 13% of the Company’s common stock, invested $100,000 in the offering; the Chambers Medical Foundation (the “Foundation”), beneficial owner of approximately 10% of the Company’s common stock, invested $100,000 in the offering; and Mr. E.P. Marinos, a director, invested $50,000 in the offering.  The Company’s Chairman of the Board is a co-trustee of the Foundation but has held no dispositive powers since his appointment as such. 

 

In October 2016, the Company and six of the seven investors in the private offering, aggregating $450,000 of the notes, including the three related parties holding $250,000 of the notes, agreed to extend the maturity dates of the notes to December 31, 2018 at a rate of 10% per annum.  One investor did not extend the maturity date and that $50,000 note was paid at maturity in December 2016.  The notes are subordinated to all indebtedness of the Company pursuant to its multi-year bank credit facility.



In connection with the subordinated promissory notes, the Company issued 100,000 warrants to purchase the Company's common stock, including 20,000 warrants to REF Securities, LLP, 20,000 warrants to the Foundation and 10,000 warrants to Mr. Marinos.  The warrants were exercisable through December 2016 at an exercise price of $3.51 per share.  In 2014, 30,000 warrants were exercised, including 20,000 by the Foundation.  No warrants were exercised in 2015 or 2016.  In October 2016, in connection with the extension of the maturity dates of the subordinated promissory notes, the expiration date of the remaining 70,000 warrants was extended to December 31, 2018.  The exercise price remained unchanged at $3.51 per share.  The 70,000 warrants remain unexercised at March 31, 2017.



In the fourth quarter of 2016, the Company calculated the incremental fair value of extending the expiration date of the Notes and Warrants and determined that the amendment represented a debt modification in accordance with the guidance outlined in ASC-470, “Debt”.  Using the Black-Scholes model, and the 10% test, the Company determined that the incremental fair value of the warrants to be $18,310 which was recorded as a reduction against the Notes and an increase in Additional Paid-in Capital. 



The discount on the notes is being recognized as non-cash interest expense over the term of the notes. The Company recorded $2,218 and $6,921 for three months ended March 31, 2017 and 2016 of non-cash interest expense related to the amortization of the discount. The unamortized discount which is net against the outstanding balance of the subordinated promissory notes is $15,771 at March 31, 2017 and $17,989 at December 31, 2016.


Income Taxes
v6.14.0.7
Income Taxes
3 Months Ended
Mar. 31, 2017
Income Taxes [Abstract]  
Income Taxes

7.  Income Taxes



No provision for income taxes has been recorded in the three months ended March 31, 2017 or 2016, respectively.    The Company has a full valuation allowance against its deferred tax assets as of March 31, 2017 and December 31, 2016. 



At March 31, 2017 the Company has federal and state net operating loss carryforwards totaling $9,124,000 and $10,780,000, respectively, which begin to expire in 2030. The Company also has federal and state tax credit carryovers of $305,800 and $188,000 respectively. The federal and state tax credits begin to expire in 2026 and 2027, respectively. 




Commitments and Contingencies
v6.14.0.7
Commitments and Contingencies
3 Months Ended
Mar. 31, 2017
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

8.  Commitments and Contingencies



Legal matters



In the ordinary course of its business, the Company is involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material impact on the Company’s financial position or results of operations.



Off-balance sheet arrangements



In the second quarter of 2016 the Company consolidated its operating leases.  Lease expense under all operating leases was approximately $7,230 and $3,322 for the three months ended March 31, 2017 and 2016, respectively. 




Shareholders' Equity
v6.14.0.7
Shareholders' Equity
3 Months Ended
Mar. 31, 2017
Shareholders' Equity [Abstract]  
Shareholders' Equity

9.  Shareholders’ Equity



Stock options and share-based incentive plan



The following table sets forth the stock option transactions for the three months ended March 31, 2017:







 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

Weighted

 

 

 



 

 

 

Weighted

 

average

 

 

 



 

 

 

Average

 

remaining

 

Aggregate



 

Number of

 

Exercise

 

contractual

 

Intrinsic



 

options

 

Price

 

term (in years)

 

Value

Outstanding at December 31, 2016

 

214,500 

 

$

5.96 

 

7.12 

 

$

17,340 

Granted

 

 —

 

 

 —

 

 

 

 

 

Exercised

 

 —

 

 

 —

 

 

 

 

 

Forfeited

 

 —

 

 

 —

 

 

 

 

 

Expired

 

 —

 

 

 —

 

 

 

 

 

Outstanding at March 31, 2017

 

214,500 

 

$

5.96 

 

6.87 

 

$

30,470 

Exercisable at March 31, 2017

 

115,495 

 

$

6.92 

 

5.37 

 

$

14,280 

Exercisable at December 31, 2016

 

109,495 

 

$

6.90 

 

5.47 

 

$

8,880 



For the three months ended March 31, 2017 and 2016, share-based compensation expense related to stock options amounted to $14,971 and $15,133, respectively, and is included in general and administrative expenses.



For the three months ended March 31, 2017,  no options were granted, exercised, forfeited or expired. 



For the three months ended March 31, 2016,  no options were granted, forfeited or expiredFor the three months ended March 31, 2016,  15,000 options were exercised generating proceeds of $51,150.



Warrants



For the three months ended March 31, 2017 and 2016, there were no warrants exercised. As of March 31, 2017,  70,000 warrants remain unexercised including 20,000 by the Company’s largest beneficial owner, REF Securities, LLP, and 10,000 by Mr. E. P. Marino, a director of the Company.  The warrants expire in December 2018.



Common Stock



For the three months ended March 31, 2017, the Company granted 4,360 shares of the Company’s common stock with a fair value of $11,250 for director fess in lieu of cash payments.  For the three months ended March 31, 2016 there were no such stock grants.

 


Subsequent Events
v6.14.0.7
Subsequent Events
3 Months Ended
Mar. 31, 2017
Subsequent Events [Abstract]  
Subsequent Events

10. Subsequent Events



Bank debt



In May 2017, the Company’s bank approved the renewal of the Company’s revolving line of credit for a one year term, maturing in June 2018, under substantially the same terms as the current revolver, subject to the Company meeting certain closing requirements.  The Company expects to receive a commitment letter from the bank in May 2017 and expects to close on the renewal in June 2017.


Inventories (Tables)
v6.14.0.7
Inventories (Tables)
3 Months Ended
Mar. 31, 2017
Inventories [Abstract]  
Inventories



 

 

 

 

 

 



 

 

 

 

 

 



 

March 31,

 

December 31,



 

2017

 

2016

Raw materials

 

$

1,055,210 

 

$

1,027,474 

Work-in-process

 

 

726,121 

 

 

537,858 

Finished goods

 

 

1,571,952 

 

 

1,494,753 

Total

 

$

3,353,283 

 

$

3,060,085 




Property, Plant and Equipment, net (Tables)
v6.14.0.7
Property, Plant and Equipment, net (Tables)
3 Months Ended
Mar. 31, 2017
Property, Plant and Equipment, net [Abstract]  
Property, Plant and Equipment, net



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

Asset Lives

 

March 31,

 

December 31,



 

(in years)

 

2017

 

2016

Machinery and equipment

 

3

to

15

 

$

17,085,287 

 

$

16,647,302 

Building and improvements

 

5

to

25

 

 

3,986,715 

 

 

3,986,715 

Vehicles

 

3

to

5

 

 

90,713 

 

 

90,713 

Furniture, fixtures, computers and software

 

3

to

5

 

 

1,508,342 

 

 

1,504,776 

Construction in progress

 

 

 

 

 

 

115,145 

 

 

402,099 

Total property, plant and equipment

 

 

 

 

 

 

22,786,202 

 

 

22,631,605 

Less: accumulated depreciation

 

 

 

 

 

 

(16,257,720)

 

 

(16,190,694)

Property, plant and equipment, net

 

 

 

 

 

$

6,528,482 

 

$

6,440,911 




Intangible Assets, net (Tables)
v6.14.0.7
Intangible Assets, net (Tables)
3 Months Ended
Mar. 31, 2017
Intangible Assets, net [Abstract]  
Intangibles Assets



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Estimated

 

March 31, 2017

 

December 31, 2016



 

Useful Life

 

 

 

 

Accumulated

 

 

 

 

 

 

 

Accumulated

 

 

 



 

(in years)

 

Gross

 

Amortization

 

Net

 

Gross

 

Amortization

 

Net

Patents and trademarks

 

10 

 

$

26,290 

 

$

10,177 

 

$

16,113 

 

$

26,290 

 

$

9,738 

 

$

16,552 

Patents and trademarks pending

 

 —

 

 

18,822 

 

 

 —

 

 

18,822 

 

 

13,541 

 

 

 —

 

 

13,541 

Total intangible assets

 

 

 

$

45,112 

 

$

10,177 

 

$

34,935 

 

$

39,831 

 

$

9,738 

 

$

30,093 




Debt (Tables)
v6.14.0.7
Debt (Tables)
3 Months Ended
Mar. 31, 2017
Debt [Abstract]  
Summary of Debt



 

 

 

 

 

 



 

 

 

 

 

 



 

March 31,

 

December 31,



 

2017

 

2016

Revolving line of credit

 

$

2,610,795 

 

$

1,785,795 

Equipment line of credit

 

$

416,949 

 

$

102,500 

Subordinated promissory notes

 

$

434,229 

 

$

432,011 



 

 

 

 

 

 

Term notes payable:

 

 

 

 

 

 

Commercial term loan

 

$

2,293,498 

 

$

2,398,870 

Equipment notes

 

 

44,854 

 

 

59,461 

Total term notes payable

 

$

2,338,352 

 

$

2,458,331 



 

 

 

 

 

 

Total Debt

 

$

5,800,325 

 

$

4,778,637 




Shareholders' Equity (Tables)
v6.14.0.7
Shareholders' Equity (Tables)
3 Months Ended
Mar. 31, 2017
Shareholders' Equity [Abstract]  
Stock Option Transactions



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

Weighted

 

 

 



 

 

 

Weighted

 

average

 

 

 



 

 

 

Average

 

remaining

 

Aggregate



 

Number of

 

Exercise

 

contractual

 

Intrinsic



 

options

 

Price

 

term (in years)

 

Value

Outstanding at December 31, 2016

 

214,500 

 

$

5.96 

 

7.12 

 

$

17,340 

Granted

 

 —

 

 

 —

 

 

 

 

 

Exercised

 

 —

 

 

 —

 

 

 

 

 

Forfeited

 

 —

 

 

 —

 

 

 

 

 

Expired

 

 —

 

 

 —

 

 

 

 

 

Outstanding at March 31, 2017

 

214,500 

 

$

5.96 

 

6.87 

 

$

30,470 

Exercisable at March 31, 2017

 

115,495 

 

$

6.92 

 

5.37 

 

$

14,280 

Exercisable at December 31, 2016

 

109,495 

 

$

6.90 

 

5.47 

 

$

8,880 




Basis of Presentation (Details)
v6.14.0.7
Basis of Presentation (Details) (USD $)
3 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Revolving line of credit 2,610,795micr_RevolvingLineOfCreditCurrentPortion $ 1,785,795micr_RevolvingLineOfCreditCurrentPortion
Revolving Credit Facility [Member]    
Debt instrument, renewal period 1 year  

Inventories (Details)
v6.14.0.7
Inventories (Details) (USD $)
Mar. 31, 2017
Dec. 31, 2016
Inventories [Abstract]    
Raw materials $ 1,055,210us-gaap_InventoryRawMaterialsNetOfReserves $ 1,027,474us-gaap_InventoryRawMaterialsNetOfReserves
Work-in-process 726,121us-gaap_InventoryWorkInProcessNetOfReserves 537,858us-gaap_InventoryWorkInProcessNetOfReserves
Finished goods 1,571,952us-gaap_InventoryFinishedGoodsNetOfReserves 1,494,753us-gaap_InventoryFinishedGoodsNetOfReserves
Total 3,353,283us-gaap_InventoryNet 3,060,085us-gaap_InventoryNet
Silver inventory $ 600,092micr_SilverInventory $ 521,746micr_SilverInventory

Property, Plant and Equipment, net (Narrative) (Details)
v6.14.0.7
Property, Plant and Equipment, net (Narrative) (Details) (USD $)
1 Months Ended 3 Months Ended
Jan. 31, 2016
item
sqft
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Property, Plant and Equipment, net [Abstract]        
Depreciation expense   $ 395,120us-gaap_Depreciation $ 361,001us-gaap_Depreciation  
Number of unoccupied buildings with letter of intent to sale 2micr_NumberOfUnoccupiedBuildingsWithLetterOfIntentToSale      
Area of building 52,000us-gaap_AreaOfRealEstateProperty      
Assets held for sale, net   $ 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup   $ 688,750us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup

Property, Plant and Equipment, net (Property, Plant and Equipment, net) (Details)
v6.14.0.7
Property, Plant and Equipment, net (Property, Plant and Equipment, net) (Details) (USD $)
3 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Property, Plant and Equipment    
Total property, plant and equipment 22,786,202us-gaap_PropertyPlantAndEquipmentGross $ 22,631,605us-gaap_PropertyPlantAndEquipmentGross
Less: accumulated depreciation (16,257,720)us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment (16,190,694)us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
Property, plant and equipment, net 6,528,482us-gaap_PropertyPlantAndEquipmentNet 6,440,911us-gaap_PropertyPlantAndEquipmentNet
Machinery and Equipment [Member]    
Property, Plant and Equipment    
Total property, plant and equipment 17,085,287us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_MachineryAndEquipmentMember
16,647,302us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_MachineryAndEquipmentMember
Building and improvements, maximum    
Property, Plant and Equipment    
Total property, plant and equipment 3,986,715us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember
3,986,715us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_BuildingAndBuildingImprovementsMember
Vehicles, maximum    
Property, Plant and Equipment    
Total property, plant and equipment 90,713us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_VehiclesMember
90,713us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_VehiclesMember
Furniture, fixtures, computers and software, maximum    
Property, Plant and Equipment    
Total property, plant and equipment 1,508,342us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_FurnitureAndFixturesMember
1,504,776us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_FurnitureAndFixturesMember
Construction in Progress [Member]    
Property, Plant and Equipment    
Total property, plant and equipment 115,145us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_ConstructionInProgressMember
$ 402,099us-gaap_PropertyPlantAndEquipmentGross
/ us-gaap_PropertyPlantAndEquipmentByTypeAxis
= us-gaap_ConstructionInProgressMember
Maximum asset life (years) | Machinery and Equipment [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 15 years  
Maximum asset life (years) | Building and improvements, maximum    
Property, Plant and Equipment    
Asset Lives (in years) 25 years  
Maximum asset life (years) | Vehicles, maximum    
Property, Plant and Equipment    
Asset Lives (in years) 5 years  
Maximum asset life (years) | Furniture, fixtures, computers and software, maximum    
Property, Plant and Equipment    
Asset Lives (in years) 5 years  
Minimum asset life (years) | Machinery and Equipment [Member]    
Property, Plant and Equipment    
Asset Lives (in years) 3 years  
Minimum asset life (years) | Building and improvements, maximum    
Property, Plant and Equipment    
Asset Lives (in years) 5 years  
Minimum asset life (years) | Vehicles, maximum    
Property, Plant and Equipment    
Asset Lives (in years) 3 years  
Minimum asset life (years) | Furniture, fixtures, computers and software, maximum    
Property, Plant and Equipment    
Asset Lives (in years) 3 years  

Intangible Assets, net (Narrative) (Details)
v6.14.0.7
Intangible Assets, net (Narrative) (Details) (USD $)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Intangible Assets, net [Abstract]    
Amortization expense $ 439us-gaap_AmortizationOfIntangibleAssets $ 439us-gaap_AmortizationOfIntangibleAssets

Intangible Assets, net (Intangible Assets) (Details)
v6.14.0.7
Intangible Assets, net (Intangible Assets) (Details) (USD $)
3 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Intangible Assets [Line Items]    
Gross $ 45,112us-gaap_FiniteLivedIntangibleAssetsGross $ 39,831us-gaap_FiniteLivedIntangibleAssetsGross
Accumulated Amortization 10,177us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization 9,738us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Net 34,935us-gaap_FiniteLivedIntangibleAssetsNet 30,093us-gaap_FiniteLivedIntangibleAssetsNet
Patents and Trademarks [Member]    
Intangible Assets [Line Items]    
Estimated Useful Life (in years) 10 years  
Gross 26,290us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
26,290us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
Accumulated Amortization 10,177us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
9,738us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
Net 16,113us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
16,552us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksMember
Patents and Trademarks Pending    
Intangible Assets [Line Items]    
Gross 18,822us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksNotYetInServiceMember
13,541us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksNotYetInServiceMember
Net $ 18,822us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksNotYetInServiceMember
$ 13,541us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= micr_PatentsAndTrademarksNotYetInServiceMember

Debt (Bank Debt Narrative) (Details)
v6.14.0.7
Debt (Bank Debt Narrative) (Details) (USD $)
1 Months Ended 3 Months Ended
Nov. 30, 2016
Mar. 31, 2017
Dec. 31, 2016
Debt Instrument [Line Items]      
Outstanding balance, line of credit   $ 2,610,795us-gaap_LineOfCredit $ 1,785,795us-gaap_LineOfCredit
Revolving Credit Facility [Member]      
Debt Instrument [Line Items]      
Amount refinanced into new debt instrument 500,000micr_AmountRefinancedIntoNewDebtInstrument
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
   
Percent borrowable of net eligible receivable   80.00%micr_PercentBorrowableOfNetEligibleReceivableRevolvingLoan
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
 
Percent Borrowable of net Eligible Raw Materials Inventory   50.00%micr_PercentBorrowableOfNetEligibleRawMaterialsInventoryRevolvingLoan
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
 
Revolver, interest rate at end of period   3.75%us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
 
Amount available under line of credit facility   848,719us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
 
Debt instrument, renewal period   1 year  
Revolving Credit Facility [Member] | Prime Rate [Member]      
Debt Instrument [Line Items]      
Spread on variable rate   0.25%us-gaap_DerivativeBasisSpreadOnVariableRate
/ us-gaap_CreditFacilityAxis
= us-gaap_RevolvingCreditFacilityMember
/ us-gaap_VariableRateAxis
= us-gaap_PrimeRateMember
 
Equipment Line of Credit [Member]      
Debt Instrument [Line Items]      
Number of debt instruments converted during period 3micr_NumberOfDebtInstrumentsConvertedDuringPeriod
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
   
Commercial Term Loan [Member]      
Debt Instrument [Line Items]      
Debt instrument, interest rate 4.65%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
   
Debt maturity period   5 years  
Approximate monthly principal and interest payment 46,500us-gaap_DebtInstrumentPeriodicPayment
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
   
Debt instrument, face amount 2,481,943us-gaap_DebtInstrumentFaceAmount
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
   
Debt issuance costs   39,712us-gaap_DeferredFinanceCostsNet
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
45,858us-gaap_DeferredFinanceCostsNet
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
Equipment Term Loan 2016 [Member] | Equipment Line of Credit [Member]      
Debt Instrument [Line Items]      
Line of credit, draw period   1 year  
Maximum borrowing capacity 1,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoan2016Member
   
Outstanding balance, line of credit   $ 416,949us-gaap_LineOfCredit
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoan2016Member
$ 102,500us-gaap_LineOfCredit
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoan2016Member
Line of credit, maturity period   6 years  
Earliest repayment period, from date of loan   1 year  
Equipment Term Loan 2016 [Member] | Equipment Line of Credit [Member] | Prime Rate [Member]      
Debt Instrument [Line Items]      
Spread on variable rate   0.25%us-gaap_DerivativeBasisSpreadOnVariableRate
/ us-gaap_CreditFacilityAxis
= us-gaap_LineOfCreditMember
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoan2016Member
/ us-gaap_VariableRateAxis
= us-gaap_PrimeRateMember
 

Debt (Other Debt Narrative) (Details)
v6.14.0.7
Debt (Other Debt Narrative) (Details) (USD $)
3 Months Ended 12 Months Ended 1 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2016
item
Oct. 31, 2016
item
Jan. 31, 2013
Dec. 31, 2013
Debt Instruments [Line Items]                  
Number of warrants issued 100,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights                
Issuance of common stock from treasury, shares     0us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued 0us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued          
Warrants unexercised 70,000us-gaap_ClassOfWarrantOrRightOutstanding                
Non-cash interest expense $ 2,218us-gaap_AmortizationOfDebtDiscountPremium $ 6,921us-gaap_AmortizationOfDebtDiscountPremium              
Subordinated promissory notes, exercise price of warrants     $ 3.51us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1     $ 3.51us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1      
REF Securities, LLP [Member]                  
Debt Instruments [Line Items]                  
Number of warrants issued 20,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
               
Warrants unexercised 20,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
               
Chambers Medical Foundation [Member]                  
Debt Instruments [Line Items]                  
Number of warrants issued 20,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
               
Issuance of common stock from treasury, shares         20,000us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
       
E.P. Marinos [Member]                  
Debt Instruments [Line Items]                  
Number of warrants issued 10,000us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
               
Warrants unexercised 10,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
               
Warrants                  
Debt Instruments [Line Items]                  
Issuance of common stock from treasury, shares         30,000us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued
/ us-gaap_ClassOfWarrantOrRightAxis
= us-gaap_WarrantMember
       
Term Debt And Equipment Notes [Member] | Equipment Term Loans [Member]                  
Debt Instruments [Line Items]                  
Number of equipment notes 2micr_NumberOfEquipmentNotes
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
               
Debt instrument, face amount               272,500us-gaap_DebtInstrumentFaceAmount
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
 
Debt instrument, interest rate 4.66%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
               
Approximate monthly principal and interest payment 5,000us-gaap_DebtInstrumentPeriodicPayment
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentTermLoansMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
               
Equipment notes, maturity period 5 years                
Subordinated Debt [Member]                  
Debt Instruments [Line Items]                  
Debt instrument, face amount             450,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
  500,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
Debt instrument, maturity date Dec. 31, 2018                
Interest rate 10.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
    12.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
        10.00%us-gaap_DebtInstrumentInterestRateEffectivePercentage
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
Period for first interest rate of debt instrument 2 years                
Payment on subordinated debt           50,000us-gaap_RepaymentsOfSubordinatedDebt
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
     
Number of investors in the private offering             7micr_NumberOfInvestorsInPrivateOffering
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
   
Number of investors, maturity date extended             6micr_NumberOfInvestorsMaturityDateExtended
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
   
Number of investors, maturity date not extended           1micr_NumberOfInvestorsMaturityDateNotExtended
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
     
Debt, fair value 18,310us-gaap_LongTermDebtFairValue
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
               
Number of largest beneficial owners 2micr_NumberOfLargestBeneficialOwners
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
               
Unamortized discount 15,771us-gaap_DebtInstrumentUnamortizedDiscount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
  17,989us-gaap_DebtInstrumentUnamortizedDiscount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
    17,989us-gaap_DebtInstrumentUnamortizedDiscount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
     
Subordinated Debt [Member] | REF Securities, LLP [Member]                  
Debt Instruments [Line Items]                  
Percent of beneficial owner of company's common stock 13.00%micr_PercentOfBeneficialOwnerOfCompanySCommonStock
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
               
Invested amount in private offering 100,000micr_InvestedAmountInPrivateOffering
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
               
Subordinated Debt [Member] | Chambers Medical Foundation [Member]                  
Debt Instruments [Line Items]                  
Percent of beneficial owner of company's common stock 10.00%micr_PercentOfBeneficialOwnerOfCompanySCommonStock
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
               
Invested amount in private offering 100,000micr_InvestedAmountInPrivateOffering
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ChambersMedicalFoundationMember
               
Subordinated Debt [Member] | E.P. Marinos [Member]                  
Debt Instruments [Line Items]                  
Invested amount in private offering 50,000micr_InvestedAmountInPrivateOffering
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
               
Subordinated Debt [Member] | Three Related Parties [Member]                  
Debt Instruments [Line Items]                  
Debt instrument, face amount             $ 250,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_SubordinatedDebtMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_ThreeRelatedPartiesMember
   

Debt (Summary of Debt) (Details)
v6.14.0.7
Debt (Summary of Debt) (Details) (USD $)
Mar. 31, 2017
Dec. 31, 2016
Debt Instrument [Line Items]    
Revolving line of credit $ 2,610,795us-gaap_LineOfCredit $ 1,785,795us-gaap_LineOfCredit
Equipment line of credit 416,949micr_EquipmentLineOfCredit 102,500micr_EquipmentLineOfCredit
Subordinated promissory notes 434,229us-gaap_SubordinatedDebt 432,011us-gaap_SubordinatedDebt
Total term notes payable 2,338,352us-gaap_DebtInstrumentCarryingAmount 2,458,331us-gaap_DebtInstrumentCarryingAmount
Total Debt 5,800,325us-gaap_DebtLongtermAndShorttermCombinedAmount 4,778,637us-gaap_DebtLongtermAndShorttermCombinedAmount
Term Debt And Equipment Notes [Member] | Commercial Term Loan [Member]    
Debt Instrument [Line Items]    
Total term notes payable 2,293,498us-gaap_DebtInstrumentCarryingAmount
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
2,398,870us-gaap_DebtInstrumentCarryingAmount
/ us-gaap_DebtInstrumentAxis
= micr_CommercialTermLoanMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
Term Debt And Equipment Notes [Member] | EQUIPMENT NOTES    
Debt Instrument [Line Items]    
Total term notes payable $ 44,854us-gaap_DebtInstrumentCarryingAmount
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentNotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember
$ 59,461us-gaap_DebtInstrumentCarryingAmount
/ us-gaap_DebtInstrumentAxis
= micr_EquipmentNotesMember
/ us-gaap_LongtermDebtTypeAxis
= us-gaap_MediumTermNotesMember

Income Taxes (Narrative) (Details)
v6.14.0.7
Income Taxes (Narrative) (Details) (USD $)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Income Taxes [Line Items]    
Income tax provision (benefit)      
Federal Tax Authority [Member]    
Income Taxes [Line Items]    
Tax credit carryforwards 305,800us-gaap_TaxCreditCarryforwardAmount
/ us-gaap_TaxCreditCarryforwardAxis
= us-gaap_DomesticCountryMember
 
State Jurisdiction [Member]    
Income Taxes [Line Items]    
Tax credit carryforwards 188,000us-gaap_TaxCreditCarryforwardAmount
/ us-gaap_TaxCreditCarryforwardAxis
= us-gaap_StateAndLocalJurisdictionMember
 
Federal Tax Authority [Member]    
Income Taxes [Line Items]    
Net operating loss carryforwards 9,124,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_DomesticCountryMember
 
State Jurisdiction [Member]    
Income Taxes [Line Items]    
Net operating loss carryforwards $ 10,780,000us-gaap_OperatingLossCarryforwards
/ us-gaap_IncomeTaxAuthorityAxis
= us-gaap_StateAndLocalJurisdictionMember
 

Commitments and Contingencies (Details)
v6.14.0.7
Commitments and Contingencies (Details) (USD $)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Commitments and Contingencies [Abstract]    
Operating lease expense, office equipment $ 7,230us-gaap_LeaseAndRentalExpense $ 3,322us-gaap_LeaseAndRentalExpense

Shareholders' Equity (Narrative) (Details)
v6.14.0.7
Shareholders' Equity (Narrative) (Details) (USD $)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of options, granted in period    0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Number of options, expired in period 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
Number of options, forfeited in period 0us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares 0us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
Number of options, exercised in period    15,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Proceeds from stock options exercises   $ 51,150us-gaap_ProceedsFromStockOptionsExercised
Warrants exercised 0micr_WarrantsExercised 0micr_WarrantsExercised
Warrants unexercised 70,000us-gaap_ClassOfWarrantOrRightOutstanding  
Common stock granted, shares 4,360us-gaap_StockIssuedDuringPeriodSharesNewIssues 0us-gaap_StockIssuedDuringPeriodSharesNewIssues
Common stock granted, values 11,250us-gaap_StockIssuedDuringPeriodValueNewIssues  
REF Securities, LLP [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrants unexercised 20,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_RefSecuritiesLlpMember
 
E.P. Marinos [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrants unexercised 10,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= micr_E.p.MarinosMember
 
Stock Option [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based compensation expense $ 14,971us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember
$ 15,133us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= us-gaap_EmployeeStockOptionMember

Shareholders' Equity (Stock Option Transactions) (Details)
v6.14.0.7
Shareholders' Equity (Stock Option Transactions) (Details) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Shareholders' Equity [Abstract]      
Number of options, outstanding, beginning balance 214,500us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber    
Weighted average exercise price, options outstanding $ 5.96us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice   $ 5.96us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Weighted average remaining contractual term (in years), options outstanding 6 years 10 months 13 days   7 years 1 month 13 days
Aggregate intrinsic value, options outstanding $ 30,470us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue   $ 17,340us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
Number of options, granted in period    0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross  
Weighted average exercise price, options granted in period       
Number of options, exercised in period    (15,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised  
Weighted average exercise price, options exercised in period       
Number of options, forfeited in period 0us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares 0us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares  
Weighted average exercise price, options forfeited in period       
Number of options, expired in period 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod  
Weighted average exercise price, options expired in period       
Number of options, outstanding, ending balance 214,500us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber   214,500us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Number of options, exercisable 115,495us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions   109,495us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
Weighted average exercise price, options exercisable $ 6.92us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice   $ 6.90us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
Weighted average remaining contractual term (in years), options exercisable 5 years 4 months 13 days   5 years 5 months 19 days
Aggregate intrinsic value, options exercisable $ 14,280us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue   $ 8,880us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue